EDGAR filings
Every filing EDGAR's full-index lists, from every filer: companies, insiders, funds and filing agents. A search that names no form type, ticker or filer CIK covers at most 31 days and defaults to the last 7.
EDGAR holds what was filed electronically. Electronic filing began in 1993 (the earliest filing here is of 1993-02-11) and was phased in filer by filer until May 1996: filings made on paper before 1993, and during the phase-in by a filer not yet on EDGAR, are not on EDGAR and therefore not here.
50 rows on this page.
| Filed | Form | Filer | Category | 8-K items / description | Accession |
|---|---|---|---|---|---|
| 2026-11-20 | SCHEDULE 13G/A |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001969764-26-000002 | |
| 2026-11-19 | 3 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001932659-26-000004 | |
| 2026-11-13 | 8-K |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001104659-26-126519 |
| 2026-11-13 | 10-Q |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Financial reports | 10-Q | 0001104659-26-126504 |
| 2026-10-28 | 8-K |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Current reports | 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing | 0001104659-26-119669 |
| 2026-09-03 | 8-K |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Current reports | 8.01 Other Events; 9.01 Financial Statements and Exhibits | 0001104659-26-105052 |
| 2026-08-12 | 8-K |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001104659-26-094466 |
| 2026-08-12 | 10-Q |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Financial reports | 10-Q | 0001104659-26-094435 |
| 2026-08-07 | SCHEDULE 13G |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0002143027-26-000012 | |
| 2026-06-15 | 8-K |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Current reports | 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers; 5.07 Submission of Matters to a Vote of Security Holders; 9.01 Financial Statements and Exhibits | 0001104659-26-074025 |
| 2026-06-12 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001970274-26-000004 | |
| 2026-06-12 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001634189-26-000002 | |
| 2026-06-12 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001616284-26-000002 | |
| 2026-06-12 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001573553-26-000002 | |
| 2026-06-12 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001570392-26-000003 | |
| 2026-06-12 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001568850-26-000002 | |
| 2026-06-12 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001242215-26-000014 | |
| 2026-05-22 | EFFECT |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Registrations and prospectuses | 9999999995-26-001747 | |
| 2026-05-20 | CORRESP |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Other | 0001104659-26-064183 | |
| 2026-05-18 | UPLOAD |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Other | 0000000000-26-005086 | |
| 2026-05-15 | SCHEDULE 13G/A |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001493215-26-000112 | |
| 2026-05-13 | S-3 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Registrations and prospectuses | 0001104659-26-060391 | |
| 2026-05-13 | 8-K |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001104659-26-059780 |
| 2026-05-13 | 10-Q |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Financial reports | 10-Q | 0001104659-26-059752 |
| 2026-05-13 | SCHEDULE 13G/A |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0000919574-26-002920 | |
| 2026-04-30 | ARS |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Financial reports | 0001104659-26-052913 | |
| 2026-04-30 | DEFA14A |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Proxies | 0001104659-26-052893 | |
| 2026-04-30 | DEF 14A |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Proxies | 0001104659-26-052880 | |
| 2026-04-20 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001437782-26-000010 | |
| 2026-04-16 | 144 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001950047-26-003561 | |
| 2026-03-26 | SCHEDULE 13G/A |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001493152-26-013007 | |
| 2026-03-23 | 3 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0002012430-26-000002 | |
| 2026-03-20 | 8-K |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Current reports | 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits | 0001104659-26-032427 |
| 2026-03-20 | 10-K |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Financial reports | 10-K | 0001104659-26-032415 |
| 2026-02-05 | 4/A |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001943112-26-000005 | |
| 2026-02-05 | 4/A |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001910985-26-000006 | |
| 2026-02-05 | 4/A |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001787700-26-000005 | |
| 2026-02-05 | 4/A |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001771207-26-000005 | |
| 2026-02-05 | 4/A |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001437782-26-000007 | |
| 2026-02-04 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001943112-26-000004 | |
| 2026-02-04 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001910985-26-000005 | |
| 2026-02-04 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001787700-26-000004 | |
| 2026-02-04 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001771207-26-000004 | |
| 2026-02-04 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001437782-26-000006 | |
| 2026-01-28 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001943112-26-000002 | |
| 2026-01-28 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001910985-26-000003 | |
| 2026-01-28 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001787700-26-000002 | |
| 2026-01-28 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001771207-26-000002 | |
| 2026-01-28 | 4 |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Ownership | 0001437782-26-000004 | |
| 2026-01-26 | 8-K |
MIST
Milestone Pharmaceuticals Inc.
CIK 1408443
|
Current reports | 8.01 Other Events; 9.01 Financial Statements and Exhibits | 0001104659-26-006483 |